Upfront

The experimental drug filgotinib blocks a set of enzymes that cause inflammation in rheumatoid arthritis patients who haven’t benefitted from other treatments, a study shows.

Anew drug combination for chronic lymphocytic leukemia could herald a new standard of treatment, researchers find.

Inflammation from a simple infection can awaken a silent genetic defect in rats that carry it, resulting in a deadly form of pulmonary hypertension, a study shows.

Brain scans of a group of adolescents in California’s Salinas Valley show a direct link between pesticides they were exposed to in utero and certain brain functions.

Stimulating cells that jump in to protect healthy tissues in MS patients when their immune systems attack could lead to new drug therapies, researcher says.

Researchers ID cells that transform into tissue that caps off plaque in atherosclerosis. They also believe they’ve found the gene responsible for the transformation.

Pivotal response therapy that taps into the interests of children with autism, is better than existing therapies at motivating them to talk, a new study shows.

Surgeon performs Stanford Medicine’s first scar-free thyroid removal.

Some groups of women with ovarian cancer are undertested for mutations that could guide clinical care.